{
    "2020-11-06": [
        [
            {
                "time": "2023-10-18",
                "original_text": "The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Drug",
                        "Flunks",
                        "COVID-19",
                        "Study",
                        "Molecular Templates",
                        "Blood Cancer",
                        "Partial Hold"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Novartis arthritis drug fails to help COVID-19 patients",
                "features": {
                    "keywords": [
                        "Novartis",
                        "arthritis",
                        "drug",
                        "fails",
                        "COVID-19",
                        "patients"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS)",
                "features": {
                    "keywords": [
                        "Novartis",
                        "update",
                        "CAN-COVID",
                        "trial",
                        "hospitalized",
                        "patients",
                        "COVID-19",
                        "pneumonia",
                        "cytokine",
                        "release",
                        "syndrome"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}